133 related articles for article (PubMed ID: 8606120)
21. Effects of micro-amounts of Porphyromonas gingivalis lipopolysaccharide on rabbit inflammatory immune response and development of atherosclerosis.
Lin G; Shi X; Chen S; Lei L; You X; Huang M; Luo L; Li Y; Zhao X; Yan F
J Periodontal Res; 2015 Jun; 50(3):356-62. PubMed ID: 25065326
[TBL] [Abstract][Full Text] [Related]
22. [Expression of triggering receptors expressed by myeloid cells-1 in macrophages stimulated by Porphyromonas gingivalis-lipopolysaccharide].
Yang Y; Chen SS; Xu CM; Wu YF; Zhao L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2018 Oct; 36(5):475-481. PubMed ID: 30465338
[TBL] [Abstract][Full Text] [Related]
23. Modulation of an interleukin-12 and gamma interferon synergistic feedback regulatory cycle of T-cell and monocyte cocultures by Porphyromonas gingivalis lipopolysaccharide in the absence or presence of cysteine proteinases.
Yun PL; DeCarlo AA; Collyer C; Hunter N
Infect Immun; 2002 Oct; 70(10):5695-705. PubMed ID: 12228299
[TBL] [Abstract][Full Text] [Related]
24. Intragingival injection of Porphyromonas gingivalis-derived lipopolysaccharide induces a transient increase in gingival tumour necrosis factor-α, but not interleukin-6, in anaesthetised rats.
Taguchi H; Aono Y; Kawato T; Asano M; Shimizu N; Saigusa T
Int J Oral Sci; 2015 Sep; 7(3):155-60. PubMed ID: 26047579
[TBL] [Abstract][Full Text] [Related]
25. Biological properties of the native and synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide.
Kumada H; Haishima Y; Watanabe K; Hasegawa C; Tsuchiya T; Tanamoto K; Umemoto T
Oral Microbiol Immunol; 2008 Feb; 23(1):60-9. PubMed ID: 18173800
[TBL] [Abstract][Full Text] [Related]
26. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL-1ra by human polymorphonuclear leukocytes in response to lipopolysaccharides from periodontopathic bacteria.
Yoshimura A; Hara Y; Kaneko T; Kato I
J Periodontal Res; 1997 Apr; 32(3):279-86. PubMed ID: 9138193
[TBL] [Abstract][Full Text] [Related]
27. Induction of anti-thymocyte/T lymphocyte antibodies in mice injected with lipopolysaccharides from periodontopathic bacteria.
Kaneko T; Hara Y; Yoshimura A; Kato I
J Periodontal Res; 1999 Feb; 34(2):105-12. PubMed ID: 10207839
[TBL] [Abstract][Full Text] [Related]
28. Serum rheumatoid factor induced by intraperitoneal administration of periodontopathic bacterial lipopolysaccharide in mice.
Hara Y; Kaneko T; Yoshimura A; Kato I
J Periodontal Res; 1996 Oct; 31(7):502-7. PubMed ID: 8915954
[TBL] [Abstract][Full Text] [Related]
29. The induction of polyclonal B-cell activation and interleukin-1 production by the 75-kDa cell surface protein from Porphyromonas gingivalis in mice.
Watanabe K; Kumada H; Yoshimura F; Umemoto T
Arch Oral Biol; 1996; 41(8-9):725-31. PubMed ID: 9022909
[TBL] [Abstract][Full Text] [Related]
30. The influence of genetic variation on the splenic T cell cytokine and specific serum antibody responses to Porphyromonas gingivalis in mice.
Gemmell E; Winning TA; Grieco DA; Bird PS; Seymour GJ
J Periodontol; 2000 Jul; 71(7):1130-8. PubMed ID: 10960020
[TBL] [Abstract][Full Text] [Related]
31. Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.
Hirschfeld M; Weis JJ; Toshchakov V; Salkowski CA; Cody MJ; Ward DC; Qureshi N; Michalek SM; Vogel SN
Infect Immun; 2001 Mar; 69(3):1477-82. PubMed ID: 11179315
[TBL] [Abstract][Full Text] [Related]
32. Porphyromonas gingivalis Differentially Modulates Cell Death Profile in Ox-LDL and TNF-α Pre-Treated Endothelial Cells.
Bugueno IM; Khelif Y; Seelam N; Morand DN; Tenenbaum H; Davideau JL; Huck O
PLoS One; 2016; 11(4):e0154590. PubMed ID: 27124409
[TBL] [Abstract][Full Text] [Related]
33. Counteracting interactions between lipopolysaccharide molecules with differential activation of toll-like receptors.
Hajishengallis G; Martin M; Schifferle RE; Genco RJ
Infect Immun; 2002 Dec; 70(12):6658-64. PubMed ID: 12438339
[TBL] [Abstract][Full Text] [Related]
34. Identification of Porphyromonas gingivalis lipopolysaccharide-binding proteins in human saliva.
Choi S; Baik JE; Jeon JH; Cho K; Seo DG; Kum KY; Yun CH; Han SH
Mol Immunol; 2011 Sep; 48(15-16):2207-13. PubMed ID: 21742380
[TBL] [Abstract][Full Text] [Related]
35. In vivo exposure to Porphyromonas gingivalis up-regulates nitric oxide but suppresses tumour necrosis factor-alpha production by cultured macrophages.
Frolov I; Houri-Hadad Y; Soskolne A; Shapira L
Immunology; 1998 Mar; 93(3):323-8. PubMed ID: 9640241
[TBL] [Abstract][Full Text] [Related]
36. Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein.
Zhou Q; Desta T; Fenton M; Graves DT; Amar S
Infect Immun; 2005 Feb; 73(2):935-43. PubMed ID: 15664935
[TBL] [Abstract][Full Text] [Related]
37. Porphyromonas gingivalis lipopolysaccharide is poorly recognized by molecular components of innate host defense in a mouse model of early inflammation.
Reife RA; Shapiro RA; Bamber BA; Berry KK; Mick GE; Darveau RP
Infect Immun; 1995 Dec; 63(12):4686-94. PubMed ID: 7591124
[TBL] [Abstract][Full Text] [Related]
38. Tetracycline inhibits Porphyromonas gingivalis lipopolysaccharide-induced lesions in vivo and TNF alpha processing in vitro.
Shapira L; Houri Y; Barak V; Soskolne WA; Halabi A; Stabholz A
J Periodontal Res; 1997 Jan; 32(1 Pt 2):183-8. PubMed ID: 9085232
[TBL] [Abstract][Full Text] [Related]
39. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells.
Coats SR; Reife RA; Bainbridge BW; Pham TT; Darveau RP
Infect Immun; 2003 Dec; 71(12):6799-807. PubMed ID: 14638766
[TBL] [Abstract][Full Text] [Related]
40. Differential expression of IL-1 beta, TNF-alpha, IL-6, and IL-8 in human monocytes in response to lipopolysaccharides from different microbes.
Agarwal S; Piesco NP; Johns LP; Riccelli AE
J Dent Res; 1995 Apr; 74(4):1057-65. PubMed ID: 7782536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
